



Sickle cell disease (SCD) is the most common genetic disease 
in Africa.[1,2] It has been recognized as a major public health 
problem by international agencies such as the World Health 
Organization and the United Nations Educational, Scientific, 
and Cultural Organization.[3,4] It is a congenital condition 
of global distribution, and its most common clinical feature 
is anemia due to chronic hemolysis.[5] Cholelithiasis is a 
well‑documented finding in SCD patients and is one of the 
most important manifestations of gallbladder (GB) disease in 
sickle cell.[6] Chronic hemolysis, with its accelerated bilirubin 
turnover, leads to a high prevalence of pigment gallstones[7-12] 
The formation of gallstones in SCD is not only from hemolytic 
causes [6,13]  but also from the abnormalities in GB function or 
bile acid metabolism.[6,14] The prevalence of GB disease in SCD 
shows a high variation in the different geographical regions 
of the world[15-17] ranging from 6% to as high as 42%.[15,16] 
Thickening of the GB wall is an important imaging feature 
of GB disease; however, it is also a relatively common and 
nonspecific finding since it is seen in a wide range of GB diseases 
and extra-cholecystic pathologic conditions.[18] Although several 
studies on SCD[1,9,19-24] have been conducted, there is a dearth of 
literature on GB disease and dimensions in SCD from South-east 
Nigeria where this study was conducted.
The objective of this study was to sonographically 
evaluate the GB of steady-state SCD patients under routine 
medical supervision at the University of Nigeria Teaching 
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Hospital (UNTH), Ituku-Ozalla, Enugu, and describe the 
various findings with a view of determining the prevalence of 
GB pathologies in SCD patients.
MaterIals and Methods
This was a prospective, cross-sectional study of 130 known 
SCD participants in steady-state, attending routine clinics at 
the Hematology and Pediatrics sickle cell clinics of UNTH, 
Ituku-Ozalla, Enugu, and 130 age and sex-matched control 
group recruited randomly from staff, students, and patients’ 
relatives. The participants’ ages ranged from 10 years to 
44 years. All ultrasound scans were performed following 
at least 6 h fast to allow for bile distension of the GB. 
Trans-abdominal multiplane scan of the GB was done using 
a Dp-2200 mindray mobile ultrasound machine equipped with 
an electronic, convex array transducer with a frequency range 
of 2.5–5MHz (35C50EB).
Cholelithiasis was seen as a hyperechoic focus inside the GB 
lumen-casting posterior acoustic shadow[25-27] while stone 
impacted, and shrunken GB was seen as two curvilinear 
hyperechoic lines separated by a thin hypoechoic space 
representing a small amount of bile between the walls of 
the GB, with acoustic shadowing, distal to the surface of the 
gallstone (s). This is called the “wall-echo shadow (WES) 
sign.”[19]
Dimensions of the GB were measured and documented. The 
data analysis was done using the Statistical Software Package 
for the Social Sciences (SPSS version 16, SPSS Inc. 233 South 
Wacker Drive, 11th Floor, Chicago, IL 60606-6412, Tel: (312) 
651-3000, Fax: (312) 651-3668). The Student’s t-test analysis 
was used to compare the means of continuous variables. 
Correlation analysis was used to correlate the findings with 
subjects’ age, weight, height, and body mass index.
Sample size determination
The sample size was determined using the following formula:
N = Z2 PQ ÷ D2[28] Where, N = minimum sample size, 
Z = estimated standard deviation = 1.960, P = prevalence 
of GBD in sickle cell in Nigeria = 9% =0.09,[19] Q = 1 − P, 
D = Degree of accuracy desired = 5% =0.05.
Therefore, the minimum sample size N = 126.
Ethical consideration
The study proposal was reviewed and approved by the UNTH, 
Health Research Ethics Committee. An Ethical clearance 
certificate with reference number UNTH/CSA/329/Vol. 5 was 
issued. Informed consent was obtained from the patients and 
patients relatives.
results
The s tudy group comprised 130 SCD subjects ; 
4 (3.1%) heterozygous (HbSC) form and 126 (96.9%) 
homozygous (HbSS) form. The age range of participants 
was 10–44 years, whereas the mean age of the subjects was 
20.3 ± 9.4. Out of 130 SCD participants, 55 (42.3%) were 
female, whereas 75 (57.7%) were male.
Forteen (10.8%) out of the 130 SCD participants had 
cholelithiasis, giving a GB disease prevalence of 10.8% 
[Table 3]. 3 (21.4%) out of these had stone impacted and 
shrunken GB with WES sign, whereas 11 (78.6%) had simple, 
uncomplicated cholelithiasis. One hundred percent of the 
heterozygous (HbSC) participants had normal GB findings. 
The healthy control group had a cholelithiasis frequency of 4 
out of 130 participants, giving a prevalence of 3.1%. 1 (25%) 
out of these had stone impacted and shrunken GB with WES 
sign while 3 (75%) had simple, uncomplicated cholelithiasis. 
Three (2.3%) of the 130 SCD subjects had thickened GB wall 
due to cholelithiasis, whereas 1 (0.8%) of the 130 control group 
had thickened GB wall due to cholelithiasis. In the study group, 
9 (64%) of the 14 cases of cholelithiasis was found in males, 
and 5 (36%) was found in females, whereas in the control 
group, 3 (75%) was seen in females and 1 (25%) in males 
[Table 1 and 2]. The overall sex distribution of cholelithiasis 
was 10 (55%) cases in males and 8 (45%) cases in females. 
There was no statistically significant difference in the overall 
sex distribution of cholelithiasis at P < 0.05 [Table 4].
dIscussIon
In this study, the GBs of 130 SCD participants were 
sonographically evaluated, and the findings documented. Most 
Table 1: Demographic characteristics of the participants












Table 2: Summary of findings in the gallbladder of sickle 
cell disease
Findings Number of cases (n=130), n (%)
GB sludge 0
Uncomplicated gallstone 11 (8.5)





Phrygian cap 3 (2.3)
Septated GB 3 (2.3)
Normal GB 110 (84.6)
Total 130 (100)
WES: Wall echo shadow, GB: Gallbladder
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of the disease conditions seen in the GB of participants were 
due to cholelithiasis. The prevalence of cholelithiasis in this 
group of participants was 10.8%. No other diseases of the GB 
were seen. This suggests that other GB diseases such as GB 
carcinoma, GB polyps, and adenomyomatosis of the GB are 
indeed rare in this environment. Several authors[20,25,29] have 
shown that cholelithiasis is common in SCD due to accelerated 
hemolysis associated with the disease. The prevalence of 
cholelithiasis in this study varies slightly with the findings of 
Akinyanju and Ladapo[20] who reported a marginally lower 
prevalence of 9% in a 1979 study carried out at the Lagos 
University Teaching Hospital using oral cholecystography. 
This slight variation, though not significant, could be due to 
the use of ultrasound in the present study, which is a more 
sensitive modality when compared to oral cholecystography. 
The prevalence of cholelithiasis in the present study is higher 
than that of Akinola et al.[21] who reported a prevalence of 6% 
in SCD patients who presented with abdominal pain at Ile Ife. 
This variation is due to the fact that Akinola et al.[21] studied 
only symptomatic patients. Nzeh et al.[29] in a study of 161 
children with SCD in Ilorin reported a cholelithiasis prevalence 
of 4.2%, which is much lower than the report of the present 
study. The lower prevalence recorded in their study could be 
due to the pediatrics age group they evaluated when compared 
with the present study which evaluated adolescents and adult 
age groups. In another study at Ilorin, Ajayi et al.[12] reported 
a gallstone prevalence of 28%, which is much higher than the 
10.8% reported in the index study. The report appears to be 
the highest cholelithiasis prevalence reported in Nigeria, as 
every other author reviewed, reported lower prevalence. The 
reason for this variation could be the predominantly adult 
age group which they studied. It could also be due to dietary 
or ethnic factors. Agholor et al.[23] in a recent study of 150 
confirmed SCD participants in Benin reported a prevalence of 
16%, which is also higher than the report of the index study. 
The difference between the report of Agholor et al.[23] and the 
present study could be due to dietary or ethnic factor as the 
age group studied by Agholor et al.[23] were predominantly 
pediatrics and adolescent age groups.
The prevalence of cholelithiasis in SCD shows a high variation 
in different geographical regions of the world.[15-17] There 
is relatively lower prevalence reported in African studies 
compared to all the studies done in America and Europe. This 
wide variation is thought to be due to dietary and environmental 
factors; the different age groups studied; selection of distinct 
populations; inclusion of symptomatic patients and imaging 
modalities used in the various studies.[20,22,25]
Although the prevalence of cholelithiasis in males tended 
to be higher than that of females in the present study, there 
was no significant difference between them. This is in 
keeping with the reports of Agholor et al.[23] On the contrary, 
Darko et al.[13] in Ghana reported a significantly higher 
prevalence of cholelithiasis in males compared with that of 
females (male-to-female ratio of 12:1). The reason for this 
male preponderance of cholelithiasis in SCD is yet to be clearly 
elucidated, though Darko et al.[13] suggested a higher frequency 
of hemolytic crisis in males.
The majority of authors agree in reporting that cholelithiasis 
increases with age. In the present study, there was the increased 
number of cases of cholelithiasis in the older age group 
compared to the younger age group; 4.8% seen in the age 
group 10–19 years, and 14.9% seen in 20 years and above.
The present study did not find cholelithiasis among 
heterozygous (HbSC) SCD subjects. This is in keeping with the 
findings of Akinola et al.,[21] who did not report cholelithiasis 
among HbSC participants in their study. It also compares 
closely in pattern with the findings of Darko et al.[13] who 
noted a relatively lower prevalence of cholelithiasis among 
HbSC compared with HbSS participants. This pattern of 
having a higher prevalence in homozygous SCD participants 
compared with the heterozygous group is consistent with the 
report of this study. However, it is at variance with the report 
of  Durosinmi et al.,[20] who reported a prevalence of 22.6% in 
HbSS and 33.3% in HbSC.
In the present study, 21.4% of the 10.8% cases of cholelithiasis 
in SCD had stone impacted and shrunken GB with WES sign. 
The sign suggests either a large gallstone or multiple small 
gallstones filling the lumen of a contracted or incompletely 
visualized GB.[19,30] The GBs of these participants were not 
visualized apart from the WES sign, which was seen in the GB 
bed. None of the reviewed authors documented the WES sign 
in SCD. However, Nzeh et al.[29] reported a 1.2% prevalence 
of nonvisualized GB in 1989. They did not elucidate if those 
cases of nonvisualized GBs were as a result of cholelithiasis, 
shrunken GB, or congenital GB malformation. Recognizing 
Table 3: Prevalence of cholelithiasis in sickle cell disease
Cholelithiasis, n (%) Total
Yes No
HbSS 14 (10.8) 112 (86.2) 126
HbSC 0 4 (3.1) 4
Total 130
HbSS: Homozygous, HbSC: Heterozygous
Table 4: Association between cholelithiasis and age in 
sickle cell disease
Variable Gall bladder disease χ2 P
Yes, n (%) No, n (%)
Gender
Male 9 (12) 66 (88) 0.279 0.597
Female 5 (9.1) 50 (90.9)
Age group (years)
10-19 4 (4.8) 79 (95.2) 8.458 0.004*
≥20 10 (14.9) 37 (85.1)
*There is a statistically significant association between the presence of 
cholelithiasis and age groups in SCD participants (P<0.05). SCD: Sickle 
cell disease
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the WES sign helps to avoid misinterpretation of a stone‑filled 
GB as a loop of bowel. This sign is diagnostic of cholelithiasis, 
but it is also suggestive of acute or chronic cholecystitis.[19,28] 
However, this must be correlated with clinical history to 
make a confident diagnosis of acute or chronic cholecystitis. 
Sometimes, instead of detecting two parallel curvilinear 
echogenic lines with distal shadow, one may see only a single 
echogenic line casting a shadow. In some patients, this is due to 
calcification within the GB wall (i.e. porcelain GB); in others, 
it may relate to poor axial resolution of the transducer.[19,28]
This study did not document GB sludge in the participants. 
On the contrary, Nzeh et al.[29] and Ma’aji et al.[26] reported 
GB sludge prevalence of 7.5% and 2.8%, respectively. This 
difference could be due to the fact that all the participants in 
this study were in a steady-state. GB sludge is commonly 
associated with prolonged fasting, total parenteral nutrition, 
pregnancy, SCD, sepsis, and treatment with ceftriaxone.[24] 
The natural history of GB sludge is variable; it may resolve 
spontaneously or may progress to gallstone development.[24]
conclusIon
1. The prevalence of cholelithiasis in SCD in South-east 
Nigeria is 10.8%, whereas the prevalence of cholelithiasis 
in the control population is 3.1%
2. Cholelithiasis is more likely to occur in SCDs than in the 
healthy control group.
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